Submission Details
| 510(k) Number | K152955 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 07, 2015 |
| Decision Date | March 22, 2016 |
| Days to Decision | 167 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K152955 is an FDA 510(k) clearance for the Great Basin Shiga Toxin Direct Test, a Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-based Assay System (Class II — Special Controls, product code PCH), submitted by Great Basin Scientific, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on March 22, 2016, 167 days after receiving the submission on October 7, 2015. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3990.
| 510(k) Number | K152955 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 07, 2015 |
| Decision Date | March 22, 2016 |
| Days to Decision | 167 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | PCH — Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-based Assay System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3990 |
| Definition | A Gastrointestinal Pathogen Panel Multiplex Nucleic Acid Assay Is A Qualitative In Vitro Diagnostic Device Intended To Simultaneously Detect And Identify Multiple Gastrointestinal Microbial Nucleic Acids Extracted From Human Stool Specimens. The Detection And Identification Of A Specific Gastrointestinal Microbial Nucleic Acid From Individuals Exhibiting Signs And/or Symptoms Of Gastrointestinal Infection Aids In The Diagnosis Of Gastrointestinal Infection When Used In Conjunction With Clinical Evaluation And Other Laboratory Findings. |